Concepts (252)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Body Composition | 28 | 2020 | 602 | 2.590 |
Why?
|
| Absorptiometry, Photon | 24 | 2022 | 234 | 1.770 |
Why?
|
| Adipose Tissue | 14 | 2020 | 704 | 1.240 |
Why?
|
| Whole-Body Counting | 4 | 2017 | 25 | 1.170 |
Why?
|
| Bone Density | 22 | 2022 | 467 | 1.100 |
Why?
|
| Phantoms, Imaging | 6 | 2013 | 1330 | 0.790 |
Why?
|
| Bone and Bones | 10 | 2022 | 605 | 0.640 |
Why?
|
| Thallium | 1 | 2017 | 11 | 0.580 |
Why?
|
| Iodides | 1 | 2017 | 16 | 0.580 |
Why?
|
| Radiation Monitoring | 1 | 2017 | 53 | 0.570 |
Why?
|
| Sodium | 4 | 2017 | 336 | 0.550 |
Why?
|
| Renal Dialysis | 2 | 2018 | 903 | 0.460 |
Why?
|
| Whole Body Imaging | 1 | 2013 | 120 | 0.410 |
Why?
|
| Models, Anatomic | 1 | 2013 | 144 | 0.410 |
Why?
|
| Monte Carlo Method | 2 | 2017 | 709 | 0.400 |
Why?
|
| Pediatric Obesity | 4 | 2022 | 375 | 0.390 |
Why?
|
| Body Weight | 11 | 2017 | 1282 | 0.350 |
Why?
|
| Calibration | 4 | 2022 | 346 | 0.300 |
Why?
|
| Pregnancy, Twin | 2 | 2018 | 169 | 0.290 |
Why?
|
| Weight Gain | 4 | 2019 | 463 | 0.280 |
Why?
|
| Breast Feeding | 2 | 2020 | 248 | 0.280 |
Why?
|
| beta-Glucans | 3 | 2013 | 35 | 0.280 |
Why?
|
| Child | 29 | 2022 | 30572 | 0.280 |
Why?
|
| Isoflavones | 3 | 2013 | 74 | 0.270 |
Why?
|
| Insulin Resistance | 3 | 2022 | 720 | 0.270 |
Why?
|
| Infant, Premature | 5 | 2020 | 832 | 0.270 |
Why?
|
| Obesity | 8 | 2019 | 2893 | 0.260 |
Why?
|
| Milk, Human | 2 | 2020 | 306 | 0.260 |
Why?
|
| Fetal Development | 2 | 2018 | 116 | 0.250 |
Why?
|
| Anthropometry | 5 | 2018 | 260 | 0.240 |
Why?
|
| Child, Preschool | 17 | 2020 | 17083 | 0.210 |
Why?
|
| Adolescent | 22 | 2022 | 32698 | 0.210 |
Why?
|
| Energy Metabolism | 3 | 2019 | 985 | 0.210 |
Why?
|
| Cardiorespiratory Fitness | 1 | 2022 | 20 | 0.210 |
Why?
|
| Potassium | 7 | 2015 | 327 | 0.200 |
Why?
|
| Adiposity | 3 | 2022 | 238 | 0.200 |
Why?
|
| Body Mass Index | 6 | 2022 | 2227 | 0.200 |
Why?
|
| Software | 3 | 2008 | 1358 | 0.200 |
Why?
|
| Pregnancy Trimesters | 2 | 2018 | 33 | 0.200 |
Why?
|
| Body Height | 4 | 2018 | 233 | 0.190 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2005 | 586 | 0.180 |
Why?
|
| Osteosclerosis | 1 | 2020 | 21 | 0.180 |
Why?
|
| Osteoporosis | 2 | 2019 | 232 | 0.180 |
Why?
|
| Dietary Supplements | 4 | 2018 | 552 | 0.180 |
Why?
|
| Birth Weight | 2 | 2018 | 323 | 0.170 |
Why?
|
| Osteogenesis Imperfecta | 1 | 2022 | 149 | 0.170 |
Why?
|
| Limb Deformities, Congenital | 1 | 2020 | 117 | 0.170 |
Why?
|
| Dwarfism | 1 | 2020 | 109 | 0.170 |
Why?
|
| Reference Values | 7 | 2018 | 1127 | 0.170 |
Why?
|
| Humans | 53 | 2022 | 270809 | 0.160 |
Why?
|
| Twins, Dizygotic | 1 | 2018 | 49 | 0.160 |
Why?
|
| Skeleton | 1 | 1998 | 8 | 0.160 |
Why?
|
| Docosahexaenoic Acids | 1 | 2019 | 81 | 0.160 |
Why?
|
| Craniofacial Abnormalities | 1 | 2020 | 251 | 0.160 |
Why?
|
| Minerals | 1 | 1998 | 72 | 0.160 |
Why?
|
| Infant | 11 | 2020 | 14003 | 0.160 |
Why?
|
| Postmenopause | 2 | 2010 | 374 | 0.150 |
Why?
|
| Body Water | 5 | 2018 | 124 | 0.150 |
Why?
|
| Exercise | 3 | 2021 | 1221 | 0.150 |
Why?
|
| Urogenital Abnormalities | 1 | 2020 | 174 | 0.150 |
Why?
|
| Calcium | 7 | 2009 | 1571 | 0.150 |
Why?
|
| Spectrum Analysis | 1 | 2018 | 144 | 0.150 |
Why?
|
| Child Development | 1 | 2020 | 267 | 0.150 |
Why?
|
| Infant Nutritional Physiological Phenomena | 2 | 2017 | 193 | 0.140 |
Why?
|
| Rothmund-Thomson Syndrome | 1 | 2017 | 49 | 0.140 |
Why?
|
| Female | 36 | 2022 | 148940 | 0.140 |
Why?
|
| Reproducibility of Results | 9 | 2008 | 6193 | 0.140 |
Why?
|
| Infant Formula | 1 | 2017 | 98 | 0.130 |
Why?
|
| Male | 31 | 2022 | 128522 | 0.130 |
Why?
|
| Infant, Newborn | 10 | 2020 | 8607 | 0.130 |
Why?
|
| Nutritional Status | 1 | 2018 | 350 | 0.130 |
Why?
|
| Equipment Failure Analysis | 1 | 2017 | 324 | 0.130 |
Why?
|
| Scintillation Counting | 1 | 2017 | 102 | 0.130 |
Why?
|
| Genetic Association Studies | 1 | 2020 | 1098 | 0.130 |
Why?
|
| Energy Intake | 1 | 2018 | 517 | 0.130 |
Why?
|
| Age Factors | 7 | 2011 | 5443 | 0.130 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2015 | 51 | 0.120 |
Why?
|
| Fractures, Bone | 1 | 2017 | 310 | 0.120 |
Why?
|
| Diet | 3 | 2020 | 1469 | 0.120 |
Why?
|
| Models, Biological | 5 | 2007 | 3187 | 0.120 |
Why?
|
| Swine | 6 | 2019 | 1517 | 0.120 |
Why?
|
| Polyvinyl Chloride | 1 | 2013 | 9 | 0.110 |
Why?
|
| Nylons | 1 | 2013 | 20 | 0.110 |
Why?
|
| Polyethylene | 1 | 2013 | 22 | 0.110 |
Why?
|
| Equipment Design | 1 | 2017 | 1207 | 0.110 |
Why?
|
| Proteins | 2 | 2018 | 2030 | 0.110 |
Why?
|
| Regression Analysis | 4 | 2008 | 1564 | 0.110 |
Why?
|
| Bariatric Surgery | 1 | 2015 | 122 | 0.110 |
Why?
|
| Adaptation, Physiological | 1 | 2015 | 340 | 0.110 |
Why?
|
| Camping | 1 | 2013 | 16 | 0.110 |
Why?
|
| Hypertension | 1 | 2022 | 1584 | 0.110 |
Why?
|
| Kidney Transplantation | 1 | 2019 | 759 | 0.110 |
Why?
|
| Menopause | 1 | 2013 | 158 | 0.100 |
Why?
|
| Weight Loss | 2 | 2015 | 628 | 0.100 |
Why?
|
| Cross-Sectional Studies | 5 | 2022 | 4495 | 0.100 |
Why?
|
| Obesity, Morbid | 1 | 2015 | 234 | 0.100 |
Why?
|
| Weight Reduction Programs | 1 | 2013 | 74 | 0.100 |
Why?
|
| Young Adult | 4 | 2020 | 22255 | 0.100 |
Why?
|
| Longitudinal Studies | 1 | 2017 | 2051 | 0.100 |
Why?
|
| Computer Simulation | 1 | 2017 | 1570 | 0.100 |
Why?
|
| Overweight | 1 | 2015 | 484 | 0.100 |
Why?
|
| Growth and Development | 1 | 2011 | 27 | 0.090 |
Why?
|
| Self Concept | 1 | 2013 | 201 | 0.090 |
Why?
|
| Metabolic Syndrome | 1 | 2015 | 367 | 0.090 |
Why?
|
| Adult | 19 | 2022 | 82074 | 0.090 |
Why?
|
| Phytoestrogens | 1 | 2010 | 25 | 0.090 |
Why?
|
| Blood Urea Nitrogen | 1 | 2010 | 97 | 0.090 |
Why?
|
| Neutron Activation Analysis | 4 | 1999 | 7 | 0.090 |
Why?
|
| Marfan Syndrome | 1 | 2012 | 146 | 0.090 |
Why?
|
| Growth Hormone-Releasing Hormone | 1 | 2009 | 17 | 0.090 |
Why?
|
| Injections, Intramuscular | 1 | 2009 | 247 | 0.080 |
Why?
|
| Growth Hormone | 1 | 2009 | 215 | 0.080 |
Why?
|
| Plant Extracts | 1 | 2010 | 220 | 0.080 |
Why?
|
| Quality of Life | 2 | 2013 | 4810 | 0.080 |
Why?
|
| Body Fluid Compartments | 2 | 2018 | 18 | 0.080 |
Why?
|
| Kidney Failure, Chronic | 1 | 2015 | 931 | 0.070 |
Why?
|
| Plasmids | 1 | 2009 | 923 | 0.070 |
Why?
|
| Plethysmography | 1 | 2007 | 39 | 0.070 |
Why?
|
| Basal Metabolism | 2 | 2018 | 86 | 0.070 |
Why?
|
| Potassium Radioisotopes | 3 | 2015 | 6 | 0.070 |
Why?
|
| Placebos | 4 | 2013 | 439 | 0.070 |
Why?
|
| Body Constitution | 2 | 1998 | 39 | 0.070 |
Why?
|
| Gestational Age | 3 | 2018 | 1160 | 0.060 |
Why?
|
| Vitamin D | 3 | 2018 | 263 | 0.060 |
Why?
|
| Software Validation | 1 | 2004 | 30 | 0.060 |
Why?
|
| Pregnancy | 4 | 2019 | 7917 | 0.060 |
Why?
|
| Sex Factors | 2 | 2008 | 2180 | 0.060 |
Why?
|
| Risk Factors | 4 | 2022 | 17867 | 0.060 |
Why?
|
| Lumbar Vertebrae | 2 | 2022 | 247 | 0.060 |
Why?
|
| Sensitivity and Specificity | 3 | 2008 | 5157 | 0.060 |
Why?
|
| Receptors, Calcitriol | 1 | 2005 | 140 | 0.060 |
Why?
|
| Femur | 2 | 2020 | 161 | 0.060 |
Why?
|
| Indicator Dilution Techniques | 1 | 2022 | 27 | 0.050 |
Why?
|
| Deuterium | 1 | 2022 | 117 | 0.050 |
Why?
|
| Evaluation Studies as Topic | 2 | 1993 | 449 | 0.050 |
Why?
|
| Blood Pressure Determination | 1 | 2022 | 113 | 0.050 |
Why?
|
| Cardiovascular Diseases | 1 | 2015 | 2220 | 0.050 |
Why?
|
| Cohort Studies | 4 | 2020 | 9464 | 0.050 |
Why?
|
| Soybean Proteins | 1 | 2000 | 20 | 0.050 |
Why?
|
| Wnt-5a Protein | 1 | 2020 | 45 | 0.040 |
Why?
|
| Dishevelled Proteins | 1 | 2020 | 55 | 0.040 |
Why?
|
| Prospective Studies | 4 | 2019 | 13422 | 0.040 |
Why?
|
| Glypicans | 1 | 2020 | 50 | 0.040 |
Why?
|
| Receptor Tyrosine Kinase-like Orphan Receptors | 1 | 2020 | 57 | 0.040 |
Why?
|
| Arthritis, Juvenile | 1 | 2000 | 58 | 0.040 |
Why?
|
| Olive Oil | 1 | 2019 | 22 | 0.040 |
Why?
|
| Polymorphism, Genetic | 1 | 2005 | 1557 | 0.040 |
Why?
|
| Emulsions | 1 | 2019 | 86 | 0.040 |
Why?
|
| Soybean Oil | 1 | 2019 | 65 | 0.040 |
Why?
|
| Fish Oils | 1 | 2019 | 89 | 0.040 |
Why?
|
| Dietary Proteins | 1 | 2000 | 247 | 0.040 |
Why?
|
| Aftercare | 1 | 2020 | 250 | 0.040 |
Why?
|
| Linear Models | 1 | 2001 | 1094 | 0.040 |
Why?
|
| Living Donors | 1 | 2019 | 174 | 0.040 |
Why?
|
| Population Surveillance | 1 | 2001 | 631 | 0.040 |
Why?
|
| Thinness | 1 | 1998 | 78 | 0.040 |
Why?
|
| Nutritional Requirements | 1 | 2018 | 183 | 0.040 |
Why?
|
| Medroxyprogesterone | 1 | 1997 | 13 | 0.040 |
Why?
|
| Amenorrhea | 1 | 1997 | 30 | 0.040 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2020 | 313 | 0.040 |
Why?
|
| Contraceptives, Oral | 1 | 1997 | 52 | 0.040 |
Why?
|
| Middle Aged | 8 | 2020 | 90570 | 0.040 |
Why?
|
| Postpartum Period | 1 | 2018 | 257 | 0.040 |
Why?
|
| RecQ Helicases | 1 | 2017 | 97 | 0.030 |
Why?
|
| Bone Remodeling | 1 | 2017 | 101 | 0.030 |
Why?
|
| Models, Structural | 2 | 1994 | 94 | 0.030 |
Why?
|
| Hypothalamic Diseases | 1 | 1997 | 42 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2022 | 1105 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2022 | 1555 | 0.030 |
Why?
|
| Lactation | 1 | 2018 | 234 | 0.030 |
Why?
|
| Triglycerides | 1 | 2019 | 610 | 0.030 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2000 | 563 | 0.030 |
Why?
|
| Double-Blind Method | 2 | 2013 | 2575 | 0.030 |
Why?
|
| Wasting Syndrome | 1 | 2015 | 21 | 0.030 |
Why?
|
| Osteogenesis | 1 | 2017 | 271 | 0.030 |
Why?
|
| Peptide YY | 1 | 2015 | 21 | 0.030 |
Why?
|
| Mothers | 1 | 2018 | 406 | 0.030 |
Why?
|
| Pennsylvania | 1 | 2015 | 68 | 0.030 |
Why?
|
| Gastrointestinal Hormones | 1 | 2015 | 25 | 0.030 |
Why?
|
| Pregnancy Outcome | 1 | 2018 | 639 | 0.030 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2020 | 461 | 0.030 |
Why?
|
| Patient Discharge | 1 | 2020 | 699 | 0.030 |
Why?
|
| Prevalence | 1 | 2022 | 3395 | 0.030 |
Why?
|
| Adipokines | 1 | 2015 | 96 | 0.030 |
Why?
|
| Animals | 8 | 2019 | 61363 | 0.030 |
Why?
|
| Texas | 4 | 2015 | 6445 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2020 | 2855 | 0.030 |
Why?
|
| Elements | 1 | 1993 | 1 | 0.030 |
Why?
|
| Leptin | 1 | 2015 | 302 | 0.030 |
Why?
|
| Analysis of Variance | 3 | 2005 | 2313 | 0.030 |
Why?
|
| Fibrillins | 1 | 2012 | 35 | 0.030 |
Why?
|
| Fibrillin-1 | 1 | 2012 | 59 | 0.030 |
Why?
|
| Pediatrics | 2 | 2018 | 1196 | 0.030 |
Why?
|
| Infant, Low Birth Weight | 1 | 1993 | 144 | 0.030 |
Why?
|
| Genetic Variation | 1 | 2020 | 2157 | 0.020 |
Why?
|
| Gamma Rays | 1 | 1993 | 237 | 0.020 |
Why?
|
| Hypocotyl | 1 | 2010 | 5 | 0.020 |
Why?
|
| Seasons | 1 | 2013 | 333 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 1993 | 920 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2013 | 602 | 0.020 |
Why?
|
| Time Factors | 4 | 2009 | 12979 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2018 | 2659 | 0.020 |
Why?
|
| Endometrium | 1 | 2013 | 457 | 0.020 |
Why?
|
| Microfilament Proteins | 1 | 2012 | 490 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2015 | 1309 | 0.020 |
Why?
|
| Insulin | 1 | 2015 | 1424 | 0.020 |
Why?
|
| Predictive Value of Tests | 3 | 2004 | 4966 | 0.020 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2009 | 155 | 0.020 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2009 | 224 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2015 | 1176 | 0.020 |
Why?
|
| United States | 2 | 2022 | 15834 | 0.020 |
Why?
|
| Europe | 2 | 2000 | 650 | 0.020 |
Why?
|
| Mexican Americans | 2 | 2000 | 330 | 0.020 |
Why?
|
| Sex Characteristics | 2 | 2000 | 425 | 0.020 |
Why?
|
| Eating | 1 | 2009 | 437 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2019 | 33860 | 0.020 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2009 | 616 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2013 | 1932 | 0.020 |
Why?
|
| Brain | 1 | 2019 | 4199 | 0.020 |
Why?
|
| Inulin | 1 | 2005 | 20 | 0.020 |
Why?
|
| Fructans | 1 | 2005 | 10 | 0.020 |
Why?
|
| Osteocalcin | 1 | 2005 | 88 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2020 | 7789 | 0.010 |
Why?
|
| Chlorine | 2 | 1994 | 15 | 0.010 |
Why?
|
| Femur Neck | 1 | 2004 | 21 | 0.010 |
Why?
|
| Immunoassay | 1 | 2005 | 212 | 0.010 |
Why?
|
| Hip Joint | 1 | 2004 | 58 | 0.010 |
Why?
|
| Polysaccharides | 1 | 2005 | 195 | 0.010 |
Why?
|
| Biomarkers | 1 | 2015 | 5050 | 0.010 |
Why?
|
| Spine | 1 | 2004 | 312 | 0.010 |
Why?
|
| Models, Animal | 1 | 2004 | 657 | 0.010 |
Why?
|
| Kinetics | 1 | 2005 | 2206 | 0.010 |
Why?
|
| Dermatomyositis | 1 | 2001 | 30 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2009 | 5053 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2013 | 5924 | 0.010 |
Why?
|
| Animal Feed | 1 | 2000 | 86 | 0.010 |
Why?
|
| Electric Conductivity | 1 | 1999 | 99 | 0.010 |
Why?
|
| New York | 1 | 1999 | 103 | 0.010 |
Why?
|
| Electric Impedance | 1 | 1999 | 101 | 0.010 |
Why?
|
| Growth | 1 | 1999 | 123 | 0.010 |
Why?
|
| Cystic Fibrosis | 1 | 2001 | 291 | 0.010 |
Why?
|
| Rett Syndrome | 1 | 2001 | 284 | 0.010 |
Why?
|
| Random Allocation | 1 | 1999 | 728 | 0.010 |
Why?
|
| Mutation | 1 | 2017 | 15922 | 0.010 |
Why?
|
| Genotype | 1 | 2005 | 4249 | 0.010 |
Why?
|
| Mice | 1 | 2017 | 35421 | 0.010 |
Why?
|
| Liver Diseases | 1 | 2001 | 601 | 0.010 |
Why?
|
| Phosphorus | 1 | 1994 | 68 | 0.010 |
Why?
|
| Algorithms | 1 | 2004 | 3908 | 0.010 |
Why?
|
| Patient Compliance | 1 | 1997 | 677 | 0.010 |
Why?
|
| Cadaver | 1 | 1993 | 202 | 0.010 |
Why?
|
| HIV Infections | 1 | 2001 | 2155 | 0.010 |
Why?
|